9069 Results

Guideline

European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer

Authors: Icro Meattini, Carlotta Becherini, Prof Liesbeth Boersma, Orit Kaidar-Person, Gustavo Nader Marta, Angel Montero, Prof Birgitte Vrou Offersen,, Marianne C Aznar, Prof Claus Belka, Prof Adrian Murray Brunt, Samantha Dicuonzo, Pierfrancesco Franco, Mechthild Krause, Mairead MacKenzie, Tanja Marinko, Livia Marrazzo, Ivica Ratosa, Astrid Scholten, Elżbieta Senkus, Hilary Stobart, Philip Poortmans, Prof Charlotte E Coles

Congress Abstract

Induction by mFOLFIRINOX followed by SIB-SBRT for the neoadjuvant treatment of pancreatic cancer.

Authors: Bouchart|, Christelle(1)*[christelle.bouchart@bordet.be];Engelholm|, Jean-Luc(2);Bali|, Maria Antonietta(2);Closset|, Jean(3);Navez|, Julie(3);Loi|, Patrizia(3);Gökburun|, Yeter(4);De Grez|, Thierry(4);Hendlisz|, Alain(5);Mans|, Laura(6);Eisendrath|, Pierre(7);Van Gestel |, Dirk(1);Moretti|, Luigi(1);Van Laethem|, Jean-Luc(6);
(1)Institut Jules Bordet ULB, Radiotherapy, Brussels, Belgium;(2)Institut Jules Bordet ULB, Radiology, Brussels, Belgium;(3)Erasme Hospital, Gastrointestinal Surgery, Brussels, Belgium;(4)CHR Namur, Gastroenterology and digestive oncology, Namur, Belgium;(5)Institut Jules Bordet ULB, Digestive oncology, Brussels, Belgium;(6)Erasme Hospital, Gastroenterology- Hepatology and Digestive Oncology, Brussels, Belgium;(7)CHU St-Pierre, Gastroenterology, Brussels, Belgium;
Show Affiliations

Journal Article

Identification of the mutation signature of the cancer genome caused by irradiation

Authors: Shun-Ichiro Kageyama, Junyan Du, Syuzo Kaneko, Ryuji Hamamoto, Shigeo Yamaguchi, Riu Yamashita, Masayuki Okumura, Atsushi Motegi, Hidehiro Hojo, Masaki Nakamura, Katsuya Tsuchihara, Tetsuo Akimoto

Congress Abstract

Machine learning to predict best clinical plan for left-sided whole breast radiotherapy

Authors:

Christian Fiandra1, Federica Cattani2, Cristina Leonardi3, Stefania Comi3, Stefania Zara4, Linda Rossi5, Barbara Alicia Jereczek-Fossa3, Umberto Ricardi1, Ben J M Heijmen6

1University of Turin, Oncology Department, Turin, Italy; 2IEO European Institute of Oncology, Radiotherapy Division, Milan, Italy; 3IEO European Institute of Oncology, Division of Radiotherapy, Milan, Italy; 4Tecnologie Avanzate, Research and Development, Turin, Italy; 5Erasmus University Medical Center, Radiation Oncology, Rotterdam, The Netherlands; 6Erasmus University Medical Center, Radiation Oncology, Turin, Italy

Show Affiliations

Journal Article

Strategies for tackling the class imbalance problem of oropharyngeal primary tumor segmentation on magnetic resonance imaging

Authors: Roque Rodríguez Outeiral, Paula Bos, Hedda J. van der Hulst, Abrahim Al-Mamgani, Bas Jasperse, Rita Simões, Uulke A. van der Heide

Congress Abstract

Does delivered OAR dose improve prediction of late toxicity in head & neck cancer patients?

Authors: Noble|, David(1)*[djn27@cantab.net];Harrison|, Karl(2);Shelley|, Leila E A(3);Bates|, Amy M(4);Bailey|, Jessica E(5);Wilson|, Megan Z(6);Romanchikova|, Marina(7);Thomas|, Simon J(8);Hoole|, Andrew(8);Jadon|, Rashmi(9);Barnett|, Gillian C(9);Benson |, Richard J(9);Jefferies|, Sarah J(9);Burnet|, Neil G(10);Jena|, Raj(1);
(1)University of Cambridge, Oncology, Cambridge, United Kingdom;(2)University of Cambridge, Cavendish Laboratory, Cambridge, United Kingdom;(3)Western General Hospital, Edinburgh Cancer Centre, Edinburgh, United Kingdom;(4)Cambridge University Hospitals NHS Foundation Trust, Cambridge Clinical Trials Centre- Box 279, Cambridge, United Kingdom;(5)Cheltenham General Hospital, Gloucestershire Oncology Centre, Cheltenham, United Kingdom;(6)University College London, Department of Medical Physics and Biomedical Engineering, London, United Kingdom;(7)National Physical Laboratory, Data Science Team, Teddington, United Kingdom;(8)Cambridge University Hospitals NHS Foundation Trust, Department of Medical Physics and Clinical Engineering, Cambridge, United Kingdom;(9)Cambridge University Hospitals NHS Foundation Trust, Oncology Centre, Cambridge, United Kingdom;(10)University of Manchester, Manchester Academic Health Science Centre and The Christie NHS Foundation Trust, Manchester, United Kingdom;
Show Affiliations

Journal Article

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours

Authors: M.T. Dillon, Z. Boylan, D. Smith, J. Guevara, K. Mohammed, C. Peckitt, M. Saunders, U. Banerji, G. Clack, S.A. Smith, J.F. Spicer, M.D. Forster, K.J. Harrington

Journal Article

Combined proton–photon treatments – A new approach to proton therapy without a gantry

Authors: Silvia Fabiano, Panagiotis Balermpas, Matthias Guckenberger, Jan Unkelbach

Congress Abstract

Modeling the first proton arc delivery sequence and investigating its efficiency improvement

Authors:

Xuanfeng Ding1, Gang Liu1, Lewei Zhao1, Di Yan1, Rohan Deraniyagala1, Craig Stevens1, Xiaoqiang Li1

1Beaumont Health, Radiation Oncology, Royal Oak, USA

Show Affiliations
*:*